Literature DB >> 23848159

Efficacy of quetiapine off-label uses: data synthesis.

Adam C Carney.   

Abstract

Quetiapine (Seroquel(®)) is a potent U.S. Food and Drug Administration (FDA)-approved antipsychotic agent that has been used extensively for off-label indications. The current study was performed to ascertain the efficacy of some of the most prevalent off-label uses of this agent. An extensive search of electronic databases was completed using the search terms quetiapine or Seroquel, off-label and anxiety, substance abuse, dementia, delirium, personality disorder, insomnia, and sleep. Data were predictably mixed according to the indication being examined. The strongest evidence exists for anxiety and delirium. Moderate evidence exists for quetiapine as a pharmacological intervention for insomnia, dementia, and specific personality disorders. Evidence for quetiapine as a treatment for substance abuse is limited. More data are needed to establish specific dosing regimens for off-label uses and to examine the dose relationship to metabolic side effects and extrapyramidal side effects to determine whether various off-label uses justify the risk incurred with using this powerful drug. Copyright 2013, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23848159     DOI: 10.3928/02793695-20130709-01

Source DB:  PubMed          Journal:  J Psychosoc Nurs Ment Health Serv        ISSN: 0279-3695            Impact factor:   1.098


  5 in total

1.  Concerns about quetiapine.

Authors:  Alan Garrity
Journal:  Aust Prescr       Date:  2015-12-01

Review 2.  Concerns about quetiapine.

Authors:  Jonathan Brett
Journal:  Aust Prescr       Date:  2015-06-01

3.  The lesser of two evils: a qualitative study of quetiapine prescribing by family physicians.

Authors:  Martina Kelly; Tim Dornan; Tamara Pringsheim
Journal:  CMAJ Open       Date:  2018-04-30

4.  Development of a Web-Based Clinical Decision Support System for Drug Prescription: Non-Interventional Naturalistic Description of the Antipsychotic Prescription Patterns in 4345 Outpatients and Future Applications.

Authors:  Sofian Berrouiguet; Maria Luisa Barrigón; Sara A Brandt; Santiago Ovejero-García; Raquel Álvarez-García; Juan Jose Carballo; Philippe Lenca; Philippe Courtet; Enrique Baca-García
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

Review 5.  The Added Value of Liquid Antipsychotics: The Case of Quetiapine.

Authors:  Georgios Papazisis; Spyridon Siafis
Journal:  Curr Clin Pharmacol       Date:  2019
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.